Article info

Download PDFPDF
Randomised controlled trial
Percutaneous coronary intervention for acute coronary syndrome: no difference in 48-h bleeding rate or vascular access-site complications with low- or standard-dose unfractionated heparin in patients initially treated with fondaparinux
  1. Correspondence to A Michael Lincoff
    Department of Cardiovascular Medicine, Cleveland Clinic, 9500 Euclid Ave, Desk J2-3, Cleveland, Ohio 44195, USA; lincofa{at}ccf.org
View Full Text

Citation

Krishnaswamy A, Lincoff AM
Percutaneous coronary intervention for acute coronary syndrome: no difference in 48-h bleeding rate or vascular access-site complications with low- or standard-dose unfractionated heparin in patients initially treated with fondaparinux

Publication history

  • First published January 12, 2011.
Online issue publication 
May 18, 2011

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.